Show Me The Evidence and The ROI: Digital Health Investing in 2023 via GSR Ventures
Health Populi
DECEMBER 6, 2022
With valuations of digital health companies expected to decline in 2023, investors in the sector are Missourian in spirit in “Show Me” mode: here, it’s all about the clinical evidence and ROI, according to a survey from GSR Ventures. conducted among over 50 major digital health venture capital investors. Most of the 50+ responses to the survey expect that in 2023, valuations for digital health companies will decrease by over 20%: that’s a net of 83% including 60% expect
Let's personalize your content